Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Talen Energy Corp V.TLN


Primary Symbol: TLN

Talen Energy Corporation owns and operates power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services in wholesale power markets in the United States, primarily in PJM and WECC, with its generation fleet principally located in the Mid-Atlantic region of the United States and Montana. The majority of its generation is produced at its zero-carbon nuclear and lower-carbon gas-fired facilities. Its generation capacity is 10,665 megawatts (MW). Its segments include PJM and Other. The PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and Talen’s natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Talen Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities.


NDAQ:TLN - Post by User

Bullboard Posts
Post by Everswanon May 21, 2009 7:02pm
87 Views
Post# 16007711

Hard data on Pancreatic cancer...

Hard data on Pancreatic cancer...
https://www.reuters.com/article/rbssHealthcareNews/idUSLL23823420090521


4601 has so many interesting chemical properties....

4601 is an IV drug. It's not a pill. It's pumped directly into blood. From there is it so small that it diffuses into all liquids, all tissues.

Oddly, PBR expression attracts 4601 like a magnet and because of that, 4601 enters selectively into cells.

4601 does not need blood vessel for distribution. Not a pill.. Superior delivery to a pill.

Now, Pancreatic cancer proliferate in absence of blood vessel yet it is PBR abundant and vulnerable to 4601.

ASCO brings a huge amount of scientific data and sets it into scientific facts.


You want 4601 to do the job.
Also, see how in article another Pharma is using the "combo with current drug" strategy.
Well,,.... 4601 is a perfect match to all known drugs.

Yup. 4601 what jewel to own....



Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse